The EGCG treatment restored the tumoricidal function of CD8+ T cells by inhibiting the PD-1/PD-L1 axis in NSCLC-bearing mice (Figure 3E,F) [91]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.